Connect with us

Diseases & Disorders

Oral Care Market to Witness Growth Acceleration During 2014 – 2020



Press Release

Parent Market Analysis

The personal care industry broadly comprises bath and shower products, colour cosmetics, skin care, hair care, oral care, and others. In recent years, personal care products are finding profound use in day to day life of consumers. This is attributed to increased consumer awareness for ubiquitous personal care products, preference for effective cosmetic products, demand for environment friendly products and natural or organic based products. Oral hygiene being a critical factor for overall health owes significance among all personal care products.

Oral Care Market Overview

The BRICS oral care market is analysed on the basis of parameters such as product type, distribution channel and countries.Increasing awareness among consumers regarding oral hygiene is anticipated to drive demand for oral care products in the near future.

Market Value Forecast

Get Sample Copy of this report at

Globally, the oral care market is estimated to be US$ 39.1 Bn in 2014 and expected to reach at US$ 50.8 Bn by 2020, by registering a CAGR of 4.5% during 2014-2020. Whereas, the BRICS oral care market it is estimated to value at US$ 10.7 Bn in 2014 and expected to reach US$ 17.3 Bn by 2020, reflecting a CAGR of 8.4% during 2014-2020. Increasing visibility of oral care products is a major driver fuelling the growth of the market in BRICS region.

Product Type Analysis

The product type classification include primary oral care and secondary oral care products. The primary oral care segment further comprises toothpaste and toothbrush, of which, the toothpaste segment contributed a significant revenue share to the overall market in 2014. Secondary oral care products segment includes mouthwash, dental floss, denture care and others which constitutes chewing gum, whitening strips and mouth fresheners. Of the aforementioned secondary oral care products, the others segment is expected to record a CAGR of 14.5% during the forecast period.

Recent product launches such as whitening toothpaste, flavoured gel toothpaste and sensitive toothpaste are among few recent product offerings, which are expected to bolster the growth of toothpaste segment.

Distribution Channel Analysis

On the basis of distribution channel, the oral care market is segmented as convenience stores, department stores, vending machines, hypermarkets & supermarkets, speciality stores and pharmacies, general merchandise retailers, direct selling and others. In 2013, the top segments General Merchandise Retailers and direct selling collectively account for 53.0% of the total oral care market. Hypermarkets & Supermarkets coupled with department store segment accounts for 27% of the market, third largest contribution. This is due to major % share of unorganized retailing in BRICS.

Get Discount on this report at

Country Analysis

Geographically, the BRICS oral care market analysis focusses on Brazil, India, Russia, China and South Africa. The top two segments China and India collectively account for 50.6% of the total oral care market in 2014 and are expected to dominate the market, representing 52.7% of share by 2020. During the forecast period, India’s contribution to overall pie is expected to increase from 18.7% to 20.0%, registering a CAGR of 9.7% during the forecast period.

In addition, the % share contribution of South Africa and Russia is expected to increase gradually by 2020, representing a decrease of 30 BPS and 200 BPS respectively. In countries such as India, Brazil, and China demand for basic as well as secondary oral care products to attain better oral hygiene is contributing towards increased % share contribution by 2020. In Russia, the demand for secondary oral care products such as mouthwash, dental floss, and others is expected to increase significantly over the forecast period.

Key Trends

Improving living standards and rising GDP are expected to drive growth of the personal care market. On the other hand, increasing consumer awareness and organised retail is fuelling growth of the overall market in Asia Pacific, which is a potentially viable region for such products as compared to other regions. BRICS represents a potentially viable market for oral care products due to increasing consumer concerns for better oral hygiene.

Moreover, growing middle-class population coupled with increasing per capita income and consumer spending by the population in BRICS is expected to bolster growth of the oral care market, specifically in BRICS. Also, increased brand awareness for products addressing with specific dental-related issues such as sensitivity and whitening are expected to drive demand for oral care products in the near future.

Demand for value-added products by consumers is a keen area for companies to enter the consolidated oral care market. Furthermore, multi-product offerings in the oral care segment is expected to increase brand visibility and recognition in the existing as well as new or untapped markets worldwide. Thus, whitening toothpaste, mouth, sensitivity toothpaste and power toothbrush are a few key areas, which need new product offerings that cater to increasing premium class consumers in developing as well as some of the developed nations.

Competitive Players Outlook

The BRICS oral care market is dominated by international players such as Colgate-Palmolive Co., Uniliver Group, Procter & Gamble Co., Koninklijke Philips N.V., Johnson & Johnson Inc. and GlaxoSmithKline Plc. However, regional players such as Dabur and Amway owe a significant share to the overall BRICS oral care market.

Buy Full Report at

This post was originally published on Health News Office

Diseases & Disorders

RNAi Therapeutics Market Business Opportunities, Current Trends & Global Industry Analysis by 2027 | Arbutus Biopharma, Silence Therapeutics, Rexahn Pharmaceuticals, F. Hoffmann-La Roche, Quark



RNAi Therapeutics Market
Press Release

RNA interference is a biological method in which molecules of RNA inhibit gene expression by neutralizing the targeted mRNA molecules. This method plays vital role in defending cells against virus. This technique is an innovative method which into the clinical trial phase, and various companies are seeking for the FDA and EU commission approval for their products and technologies. The RNAi therapeutic are formulated to treat diseases such as cancer, haemophilia, age related diseases, and others.

This market research report provides a big picture on “RNAi Therapeutics Market”, on a Global basis, offering a forecast and statistic in terms of revenue during the forecast period. The report covers a descriptive analysis with detailed segmentation, complete research and development history, latest news and press releases. Furthermore, the study explains the future opportunities and a sketch of key players involved in the “RNAi Therapeutics Market’s hike in terms of revenue.

Every crucial and decisive detail for the development of the market and the restraining factors that may hamper the market in near future is mentioned with solutions in the report. Segmentations of the market are studied specifically to give profound knowledge for supplementary market investments.

Get Sample Copy of this Report @

Companies Mentioned:-

  • Alnylam Pharmaceuticals, Inc.
  •  Sanofi
  •  GlaxoSmithKline plc
  •  Benitec Biopharma
  •  Arbutus Biopharma Corporation
  •  Silence Therapeutics
  •  Rexahn Pharmaceuticals, Inc
  •  F. Hoffmann-La Roche Ltd
  •  Quark

The RNAi therapeutics market is forecasted to grow due to the key factors such as rising chronic diseases such as cancer, genetic disorders, and cardiovascular diseases among others. The growth of the market is also expected to grow due to rising technological development and growing FDA approvals for RNAi therapeutics. The growth of the market is expected to have growth opportunities in the emerging nations were healthcare facilities and developments are rising significantly.

The global RNAi Therapeutics market is segmented on the basis of molecule type, application, route of administration, and end user.

Based on the molecule type the market is segmented as small interfering RNAs (siRNA), and microRNA (miRNA).

On the basis of application the market is classified as genetic disorders, oncology, neurodegenerative disorders, cardiovascular, respiratory disorders, infectious diseases, renal diseases, and others.

Based on the route of administration the market is categorized as intradermal injections, pulmonary delivery, intravenous injections, intraperitoneal injections, and others.

On the basis of end user the market is divided into diagnostic laboratories, research and academic laboratories, and hospitals

The report assists in determining and analyzing the Key market players’ portfolios with information such as company profiles, components and services offered, financial information of last 3 years, key developments in past five years and helps in constructing strategies to gain competitive advantage. The market payers from RNAi Therapeutics Market are anticipated to lucrative growth opportunities in the future with the rising demand for RNAi Therapeutics in the global market. Below mentioned is the list of few companies engaged in the RNAi Therapeutics market.

Purchase this Report @

Key Benefits of Buying this Research Study:

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global RNAi Therapeutics Market

– Highlights key business priorities in order to assist companies to realign their business strategies

– The key findings and recommendations highlight crucial progressive industry trends in the RNAi Therapeutics Market, thereby allowing players across the value chain to develop effective long term strategies

– Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

– Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it

– Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

– Examine the political, economic, social and technology impact of the five regions namely: North America, Europe, Asia Pacific, Middle East & Africa and South America.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense. 

Contact Us:

Call: +1-646-491-9876

Email: [email protected]


This post was originally published on Health News Office

Continue Reading

Diseases & Disorders

Coronary Stents Market by 2022: Industry Trends, Competitor Analysis and Money Makers



Press Release

Coronary stents are small elastic tubes used for the treatment of narrowed and blocked coronary arteries in patients with coronary artery disease (CAD). These reduce the symptoms of chest pain (angina) and aid in the treatment of a heart attack. These types of stents are also called as heart stents or cardiac stents. They comprise metal mesh and are implanted in constricted coronary arteries during a technique known as percutaneous coronary intervention (PCI) or angioplasty.

The Global Coronary Stents Market was valued at $4,806 million in 2015, and is projected to reach at $9,003 million by 2022, growing at a CAGR of 9.5% from 2016 to 2022. The drug-eluting stents (DES) segment accounted for nearly half of the total market in 2015.

Download Report Sample @

In 2015, Asia-Pacific and LAMEA collectively accounted for one-fourth of the total coronary stents market and are expected to continue this trend due to increase in stents development, specifically in China, India, and the other developing countries. Rise in geriatric population is the main reason for the growth of coronary stents market in the Asia-Pacific region.

The major company profiles Are:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • C.R. Bard, Inc.
  • Medtronic plc.
  • Microport Scientific Corporation
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Biotronik SE & Co. KG
  • Biosensors International Group, Ltd.
  • Stentys SA.

Get Upto 30% Discount- Enquire Now @

The other companies that are included Are:

  • Meril Life Sciences Pvt. Ltd.
  • Vascular Concepts Limited
  • Translumina GmbH
  • REVA Medical, Inc.
  • Elixir Medical Corporation.

Factors that drive the growth of the global coronary stents market are increase in prevalence of CAD, improved patient outcomes with stenting, and emergence of new trends in the field of coronary artery stents. In addition, increase in demand for coronary stents from the emerging countries and growth in awareness about availability of suitable insurance & reimbursement policies provide opportunities to the coronary stents manufacturers. However, high cost of procedures associated with coronary stents and availability of substitute method for the treatment of CAD are expected to hamper the market growth.

DES is expected to maintain its dominant position throughout the analysis period, owing to its significant property of preventing the growth of scar tissue (restenosis) in the arterial wall after the procedure. In addition, with the advancements in stents field, DES have been significantly improved and show reduction in stent thrombosis. Moreover, they provide improved outcomes for patients with CAD treated with percutaneous coronary intervention (PCI).

The metallic biomaterials segment dominated with three-fourths of the market, in 2015, owing to cost-effectiveness of these materials. Metallic biomaterials provide efficacy of vascular healing as compared to other materials. These are used to manufacture expandable and drug-eluting stents. The global metallic biomaterials market segment is expected to grow at a CAGR of 9.5%.

Key Findings of the Coronary Stents Market Study:

  • The bio-absorbable stents are anticipated to grow at a highest rate during the analysis period from 2016 to 2022.
  • Asia-Pacific is projected to maintain its lead position throughout 2022, growing at a CAGR of 11.5%.
  • The metallic biomaterial segment occupied more than half of the total market in 2015.
  • China occupied one-fourth of the share of the total Asia-Pacific coronary stents market in 2015.
  • India is expected to grow at the highest CAGR of 14.2% from 2016 to 2022

Similar Reports:

Stents Market

Radioactive Stents Market

Pancreatic Stents Market

Catheters Market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.


David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]

This post was originally published on Health News Office

Continue Reading

Diseases & Disorders

Disposable Hospital Supplies Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2019-2022



Press Release

Disposable Hospital Supplies Market: adds “Disposable Hospital Supplies Global Market Report 2022” reports to its database.

Executive Summary

The disposable hospital supplies market consists of sale of disposable hospital supplies and related services. Disposable hospital supplies are products for one-time use only and include blood glucose test strips, procedure kits and trays, conventional syringes and needles, facemasks, prefilled syringes, isolation gowns and medical gloves.

The global disposable hospital supplies market was valued at about $19.4 billion in 2018 and is expected to grow to $28.3 billion at a CAGR of 9.9% through 2022.

The disposable hospital supplies market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. The North American Market is the largest market for disposable hospital supplies and is expected to continue to do so during the forecast period.

Request Free Sample Report @

The increase in demand for disposable hospital supplies to avoid contamination and hospital-acquired infections (HAIs) is driving the disposable hospital supplies market.

The hospitalized patients are susceptible to infections caused by various bacteria such as Staphylococcal infections and Methicillin resistant Staphylococcus aureus (MRSA) and therefore, use of sterile and unused hospital supplies is very important.

The Center for Disease Control (CDC) estimates that HAIs account for an estimated 1.7 million infections and 99,000 associated deaths each year in United States. To avoid contamination and transmission of infection in hospital settings, CDC has recommended the use of high barrier drapes, gowns, gloves and high-level disinfectants in hospital and ambulatory operating rooms. This increased use of disposable hospital supplies to avoid infections will drive the market growth.

The rising environmental concerns due to improper disposal of disposal hospital supplies will restraint the market growth, reducing their use. In healthcare facilities, disposable gloves and gowns are widely used to maintain sterile environment and reduce the risk of spreading infections from healthcare providers during invasive procedures and spread of infections from patient-to-patient. Environment regulatory bodies are imposing stringent rules for proper and managed disposal of hospital wastes. For instance, in United States, contaminated gloves, are disposed of in orange bags or orange-lidded containers based on the law guidance laid by the Royal College of Nursing.

In United States, personal protective equipment (PPE) used in healthcare settings which include disposable hospital supplies, such as surgical masks, N95 respirators, gloves, and gowns are regulated by FDA under the Premarket Notification or 510(k) Clearance Act. According to the act, the manufacturers must follow Occupational Safety and Health Administration (OSHA) regulations and must meet applicable voluntary standards for protection of healthcare providers and patients from contamination and transmission of infections.

Major players in the market are Abbott Laboratories, Bayer AG, Becton, Dickinson, and Company and Cardinal Health Incorporated, Domtar Corporation.


For further information on this report, visit –

Contact Us:


Partner Relations & Marketing Manager

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

This post was originally published on Health News Office

Continue Reading